When the wind rises and clouds soar—among U.S.-listed lithium resource companies, which one stands out? An in-depth analysis of Albemarle (ALB)

【Answer 1】 Highlights for Q2 2021 (Unless otherwise noted, all percentage changes are year-over-year comparisons) 1. Net income: $424.6 million 2. Adjusted diluted earnings per share (EPS): $0.89, up 4% 3. Net sales: $773.9 million, up 1%; net sales up 5% excluding FCS 4. Adjusted EBITDA: $194.6 million, up 5%; adjusted EBITDA up 13% excluding FCS 5. Revised full-year 2021 guidance to reflect better-than-expected lithium performance, lower interest expenses and tax rate—partially offset by rising bromine raw material costs and supply chain disruptions; updated guidance also reflects the sale of FCS 6. Completed the sale of FCS on June 1, 2021, for approximately $570 million in a cash-and-stock transaction 7. La Negra III/IV commissioning is underway, with commercial production expected in the first half of 2022 Fueled by persistently strong demand for lithium and bromine products, Albemarle delivered another robust quarter, generating $195 million in adjusted EBITDA. The company is now in the final stages of two lithium projects, which are expected to double its lithium production capacity to approximately 175,000 metric tons. This includes La Negra III/IV—already constructed and currently undergoing commissioning. Albemarle remains firmly focused on advancing all lithium projects to meet customer demand and accelerate profitable growth. Let’s focus specifically on revenue and growth in the lithium segment: Lithium net sales totaled $320.3 million, an increase of $36.6 million (+13% YoY), driven primarily by higher volumes (+17%), largely attributable to accelerated orders under long-term agreements. Average realized prices for carbonate and technical-grade products were lower this quarter, resulting in a slight year-over-year price decline (-4%). Adjusted EBITDA for lithium was $109.4 million, up $14.9 million YoY—mainly due to higher net sales and increased spodumene output from the Talison joint venture. Current trends: Full-year 2021 volume growth is expected to be ~15% YoY, driven by North American plant restarts, productivity improvements, and tolling arrangements. Average realized prices are expected to rise sequentially but remain flat year-over-year. Full-year 2021 adjusted EBITDA is projected to grow 10–15% YoY. Due to higher lithium project-startup costs—and efficiency gains only partially offsetting tolling expenses—full-year 2021 average margins are expected to remain below 35%. Albemarle’s Wave 2 growth initiatives continue progressing: La Negra III/IV is in commissioning; Kemerton I remains on track for completion later this year.

The 'white petroleum' of the carbon neutrality era: time for a revaluation of lithium mining assets—ALB, SQM, and LTHM

【Answer 2】 From a growth perspective, Albemarle’s revenue CAGR over the past five years was -3.04%, while its net profit CAGR stood at 2.33%. Its free cash flow performed relatively well, posting a strong CAGR of 17.24%. Financially, however, Albemarle does not appear to be an ideal investment candidate—it exhibits pronounced cyclicality. That said, this situation could change dramatically going forward, as lithium demand is poised for explosive growth in the years ahead. On the revenue front, Albemarle’s top line has been steadily expanding over recent years, though it declined in 2020 due to pandemic-related headwinds. By business segment, bromine and catalyst operations have remained stable; future earnings growth will stem predominantly from lithium sales. 4. Highlights for Q2 2021 (Unless otherwise noted, all percentage changes are year-over-year comparisons) • Net income: $424.6 million—or $3.62 per diluted share—including gains from the sale of the Fine Chemical Services (FCS) business • Adjusted diluted EPS: $0.89, up 4% • Net sales: $773.9 million, up 1%; net sales up 5% excluding FCS • Adjusted EBITDA: $194.6 million, up 5%; adjusted EBITDA up 13% excluding FCS • Revised full-year 2021 guidance to reflect stronger-than-expected lithium performance, lower interest expenses and tax rate—partially offset by rising bromine raw material costs and supply chain disruptions; updated guidance also reflects the FCS divestiture • Completed the sale of FCS on June 1, 2021, for approximately $570 million in a cash-and-stock transaction • La Negra III/IV commissioning is underway, with commercial production expected in the first half of 2022 Fueled by persistently strong demand for lithium and bromine products, Albemarle delivered another robust quarter, generating $195 million in adjusted EBITDA. The company is now in the final stages of two lithium projects, which are expected to double its lithium production capacity to approximately 175,000 metric tons. This includes La Negra III/IV—already constructed and currently undergoing commissioning. Albemarle remains firmly focused on advancing all lithium projects to meet customer demand and accelerate profitable growth. Let’s focus specifically on revenue and growth in the lithium segment: Lithium net sales totaled $320.3 million, an increase of $36.6 million (+13% YoY), driven primarily by higher volumes (+17%), largely attributable to accelerated orders under long-term agreements. Average realized prices for carbonate and technical-grade products were lower this quarter, resulting in a slight year-over-year price decline (-4%). Adjusted EBITDA for lithium was $109.4 million, up $14.9 million YoY—mainly due to higher net sales and increased spodumene output from the Talison joint venture.

Albemarle (ALB) Dips to Year-to-Date Low Despite Mizuho Upgrade on Battery Storage Demand

Oct 14, 2026

Albemarle shares hit a year-to-date low despite a Mizuho upgrade citing strong battery storage demand, as investors remain cautious over valuation and profitability concerns.

GuruFocus

2026-05-06

Albemarle Shares Jump as Lithium Recovery Delivers Earnings Beat

2026-09-03

Albemarle Appoints New CEO After 7 Years

2026-09-10

Albemarle, Chile Union Leaders Reach Deal; Ratification Required

2026-09-17

Albemarle Corp. Stock Outperforms Competitors on Strong Trading Day

2026-09-17

Albemarle Awards 10,867 RSUs to Chief Commercial Officer